Related Experiment Videos
Triptans for migraine management in adolescents
1Premier Research Institute, Palm Beach Headache Center, West Palm Beach, Florida 33407, USA.
Headache
|December 17, 2002
Summary
Triptans may effectively treat adolescent migraine headaches. Clinical trial data show similar tolerability to adults, but success varies with treatment timing and placebo response rates.
Area of Science:
- Neurology
- Adolescent Medicine
Background:
- Migraine is a prevalent headache disorder in adolescents.
- Currently, no migraine-specific medications are FDA-approved for adolescent use.
- Triptans are effective for adult migraines but lack adolescent approval.
Purpose of the Study:
- To review triptan efficacy and tolerability data in adolescents.
- To aid clinicians in selecting appropriate triptans for this age group.
Main Methods:
- Review of recent triptan clinical trials in adolescent migraine sufferers (ages 12-17).
- Summarization of trial results regarding efficacy and tolerability.
Main Results:
- Triptan success in adolescents is influenced by treatment initiation time (1.9-6 hours post-onset).
- Placebo response rates varied significantly (25%-57%).
- Triptan tolerability in adolescents mirrors that observed in adult populations.
Conclusions:
- Triptans show potential as an effective antimigraine treatment for adolescents.
- Further research is needed to optimize treatment timing and understand placebo effects.